References
- Martín R, Chain F, Miquel S, Natividad JM, Sokol H, Verdu EF, Langella P, Bermúdez-Humarán LG. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation. Hum Vaccin Immunother 2014; 10; http://dx.doi.org/10.4161/hv.28549; PMID: 24732667
References
- Henein A. What are the limitations on the wider therapeutic use of phage?. Bacteriophage 2013; 3:e24872; http://dx.doi.org/10.4161/bact.24872; PMID: 24228220
References
- Unterholzner SJ, Poppenberger B, Rozhon W. Toxin-antitoxin systems: Biology, identification, and application. Mob Genet Elements 2013; 3:e26219; http://dx.doi.org/10.4161/mge.26219; PMID: 24251069